Search

everythinglearnresearchcommunity

for

Search:↓

Applying the anti-cancer drug Bortezomib to skin can promote hair growth and increase hair proteins through the GATA-3 factor.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Tofacitinib may help hair regrowth in familial alopecia areata with immune issues, but more research is needed.

Using minoxidil and tofacitinib together can effectively treat severe hair loss.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

The NUDT15 gene variant causes severe side effects from azathioprine in some Indian patients.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

ADCs can effectively treat breast cancer but may cause side effects like nausea and hair loss.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

Tofacitinib improved hair and nail conditions in a teen with alopecia areata.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

Nanoparticle delivery can reduce side effects of the cancer drug doxorubicin.

Nail changes from immunotherapy can be managed without stopping cancer treatment.

Thiopurines help treat IBD but require genetic testing to avoid side effects.

Potassium channel activators like nicotinamide and minoxidil might help treat solid tumors.

The new drug delivery system effectively targets lung cancer cells.

A3B5 can reduce skin pigmentation and slow melanoma growth.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Genetic screening for NUDT15 polymorphisms is crucial for patients taking azathioprine, especially in Asians.

Tofacitinib is effective for treating alopecia totalis and universalis, with some patients experiencing significant hair regrowth.

Ruxolitinib cream may help treat severe hair loss in children.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

TS-13 effectively stops tumor growth and reduces chemotherapy side effects.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

TSC2-/meth cells can cause skin lesions, hair growth, and lung issues, and may be treated with chromatin remodeling agents.

Onabotulinum toxin A may help treat trichotillomania and promote hair growth.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Most pediatric cancer patients at Muhimbili National Hospital in Tanzania experienced side effects from chemotherapy, with nausea, hair loss, and low white blood cell count being the most common.